$BKYI
BIO KEY INTERNATIONAL INC

2017 Q2 Form 10-Q Financial Statement

#000143774917014745 Filed on August 14, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $886.9K $415.8K
YoY Change 113.29% -81.7%
Cost Of Revenue $796.0K $136.5K
YoY Change 483.16% -6.12%
Gross Profit $90.92K $279.3K
YoY Change -67.45% -86.87%
Gross Profit Margin 10.25% 67.18%
Selling, General & Admin $1.431M $1.039M
YoY Change 37.76% 6.03%
% of Gross Profit 1574.14% 371.94%
Research & Development $449.0K $566.4K
YoY Change -20.73% 43.77%
% of Gross Profit 493.89% 202.79%
Depreciation & Amortization $410.0K $20.00K
YoY Change 1950.0% 0.0%
% of Gross Profit 450.95% 7.16%
Operating Expenses $1.880M $1.605M
YoY Change 17.12% 16.85%
Operating Profit -$1.789M -$1.326M
YoY Change 34.94% -275.97%
Interest Expense $0.00 -$50.00K
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $8.00 -$49.46K
YoY Change -100.02% 12142.82%
Pretax Income -$1.790M -$1.380M
YoY Change 29.71% -284.0%
Income Tax
% Of Pretax Income
Net Earnings -$1.789M -$2.539M
YoY Change -29.52% -437.08%
Net Earnings / Revenue -201.76% -610.54%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.238M -$2.000M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $990.0K $2.010M
YoY Change -50.75% 617.86%
Cash & Equivalents $988.3K $2.007M
Short-Term Investments
Other Short-Term Assets $29.46K $2.323K
YoY Change 1168.27% -96.68%
Inventory $567.2K $480.0K
Prepaid Expenses
Receivables $847.9K $2.299M
Other Receivables $30.00K $0.00
Total Short-Term Assets $4.736M $9.881M
YoY Change -52.07% 303.29%
LONG-TERM ASSETS
Property, Plant & Equipment $153.5K $91.08K
YoY Change 68.56% 13.85%
Goodwill
YoY Change
Intangibles $166.7K $140.9K
YoY Change 18.31%
Long-Term Investments
YoY Change
Other Assets $10.00K $10.00K
YoY Change 0.0% 0.0%
Total Long-Term Assets $10.65M $7.241M
YoY Change 47.11% 2916.97%
TOTAL ASSETS
Total Short-Term Assets $4.736M $9.881M
Total Long-Term Assets $10.65M $7.241M
Total Assets $15.39M $17.12M
YoY Change -10.12% 536.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $333.6K $696.4K
YoY Change -52.09% -19.95%
Accrued Expenses $421.4K $350.8K
YoY Change 20.1% -20.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.975M $1.720M
YoY Change 14.84% -11.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.975M $1.720M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.975M $1.720M
YoY Change 14.84% -11.36%
SHAREHOLDERS EQUITY
Retained Earnings -$65.95M -$61.15M
YoY Change 7.84%
Common Stock $649.00 $6.634K
YoY Change -90.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.41M $15.40M
YoY Change
Total Liabilities & Shareholders Equity $15.39M $17.12M
YoY Change -10.12% 536.48%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$1.789M -$2.539M
YoY Change -29.52% -437.08%
Depreciation, Depletion And Amortization $410.0K $20.00K
YoY Change 1950.0% 0.0%
Cash From Operating Activities -$970.0K -$1.240M
YoY Change -21.77% -12500.0%
INVESTING ACTIVITIES
Capital Expenditures -$130.0K -$30.00K
YoY Change 333.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$130.0K -$30.00K
YoY Change 333.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 930.0K -200.0K
YoY Change -565.0% 566.67%
NET CHANGE
Cash From Operating Activities -970.0K -1.240M
Cash From Investing Activities -130.0K -30.00K
Cash From Financing Activities 930.0K -200.0K
Net Change In Cash -170.0K -1.470M
YoY Change -88.44% 7250.0%
FREE CASH FLOW
Cash From Operating Activities -$970.0K -$1.240M
Capital Expenditures -$130.0K -$30.00K
Free Cash Flow -$840.0K -$1.210M
YoY Change -30.58% -12200.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
bkyi Amortization Of Software License Rights
AmortizationOfSoftwareLicenseRights
729755
bkyi Amortization Of Software License Rights
AmortizationOfSoftwareLicenseRights
bkyi Class Of Warrant Or Right Nonemployee Compensation Expense
ClassOfWarrantOrRightNonemployeeCompensationExpense
11625
CY2017Q2 bkyi Committed Equity Facility Amount
CommittedEquityFacilityAmount
5
CY2017Q2 bkyi Committed Equity Facility Term
CommittedEquityFacilityTerm
P3Y
CY2017Q2 bkyi Equity Facility Aggregate Sales Limitation Percentage Of Total Outstanding Share
EquityFacilityAggregateSalesLimitationPercentageOfTotalOutstandingShare
0.1999
bkyi Expected Operational Costs Per Month
ExpectedOperationalCostsPerMonth
592000
CY2017Q2 bkyi Factored Accounts Receivable Factored Amount
FactoredAccountsReceivableFactoredAmount
88388
CY2016Q4 bkyi Factored Accounts Receivable Factored Amount
FactoredAccountsReceivableFactoredAmount
160918
CY2017Q2 bkyi Factored Accounts Receivable Original Invoice Value
FactoredAccountsReceivableOriginalInvoiceValue
117850
CY2016Q4 bkyi Factored Accounts Receivable Original Invoice Value
FactoredAccountsReceivableOriginalInvoiceValue
214556
CY2011Q4 bkyi Factoring Arrangement Term
FactoringArrangementTerm
P2Y
CY2017Q2 bkyi Factoring Fees
FactoringFees
85326
CY2016Q2 bkyi Factoring Fees
FactoringFees
108351
bkyi Factoring Fees
FactoringFees
133717
bkyi Factoring Fees
FactoringFees
303363
bkyi Increase Decrease In Software License Rights
IncreaseDecreaseInSoftwareLicenseRights
-75648
bkyi Increase Decrease In Software License Rights
IncreaseDecreaseInSoftwareLicenseRights
CY2017Q2 bkyi Maximum Dollar Amount Of Shares To Purchase Based On Daily Volume Weighted Average Price Of The Companys Common Stock
MaximumDollarAmountOfSharesToPurchaseBasedOnDailyVolumeWeightedAveragePriceOfTheCompanysCommonStock
100000
CY2017Q2 bkyi Maximum Ownership Of Companys Common Stock Requirement Under Committed Equity Facility Sale Percentage
MaximumOwnershipOfCompanysCommonStockRequirementUnderCommittedEquityFacilitySalePercentage
0.0999
CY2017Q2 bkyi Per Share Price That Is Used In Calculation For Purchase Price Under Committed Equity Facility
PerSharePriceThatIsUsedInCalculationForPurchasePriceUnderCommittedEquityFacility
3.83
CY2017Q2 bkyi Percentage Of Lowest Vwap That Equals Or Exceeds Specified Per Share Price Under Committed Equity Facility
PercentageOfLowestVWAPThatEqualsOrExceedsSpecifiedPerSharePriceUnderCommittedEquityFacility
0.94
bkyi Percentage Of Remaining Balance Owned Reserved
PercentageOfRemainingBalanceOwnedReserved
0.48
CY2017Q2 bkyi Period For Maximum Dollar Amount Of Shares To Purchase
PeriodForMaximumDollarAmountOfSharesToPurchase
P5D
bkyi Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value Amount
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValueAmount
20538
CY2017Q2 bkyi Software License Rights
SoftwareLicenseRights
11353008
CY2016Q4 bkyi Software License Rights
SoftwareLicenseRights
12158411
CY2017Q2 bkyi Software License Rights Current
SoftwareLicenseRightsCurrent
2100000
CY2016Q4 bkyi Software License Rights Current
SoftwareLicenseRightsCurrent
1560000
CY2017Q2 bkyi Software License Rights Noncurrent
SoftwareLicenseRightsNoncurrent
9253008
CY2016Q4 bkyi Software License Rights Noncurrent
SoftwareLicenseRightsNoncurrent
10598411
bkyi Stock Based Fees To Directors And Consulants
StockBasedFeesToDirectorsAndConsulants
10008
bkyi Stock Based Fees To Directors And Consulants
StockBasedFeesToDirectorsAndConsulants
39999
CY2017Q2 bkyi Stock Issued During Period As A Commitment Fee Shares
StockIssuedDuringPeriodAsACommitmentFeeShares
55000
CY2017Q2 bkyi Stock Issued During Period As A Commitment Fee Value
StockIssuedDuringPeriodAsACommitmentFeeValue
198000
CY2017Q2 bkyi Stock Issued During Period Issued For Services Weighted Average Share Price
StockIssuedDuringPeriodIssuedForServicesWeightedAverageSharePrice
2.54
CY2015Q1 bkyi Term Of Warrant
TermOfWarrant
P1Y
CY2017Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
29462
CY2016Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
53638
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
333627
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
466842
CY2017Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
2931674
CY2016Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
3647031
CY2017Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
861674
CY2016Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1577031
CY2017Q2 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
2070000
CY2016Q4 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
2070000
CY2017Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
1917889
CY2016Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
3133246
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
847889
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1563246
CY2017Q2 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1070000
CY2016Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1570000
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
421350
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
335323
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
79359032
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
78253413
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
413194
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
49935
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
574283
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
224298
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13785
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13785
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
500000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
1000000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6833
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6803
CY2017Q2 us-gaap Assets
Assets
15387972
CY2016Q4 us-gaap Assets
Assets
17289365
CY2017Q2 us-gaap Assets Current
AssetsCurrent
4735988
CY2016Q4 us-gaap Assets Current
AssetsCurrent
4910296
CY2017Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
10651984
CY2016Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
12379069
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
988342
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1061307
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4321078
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2006665
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-72965
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2314413
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.52
CY2015Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
47917
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493290
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6093843
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493290
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6093843
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
649
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
609
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
795961
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
136490
us-gaap Cost Of Revenue
CostOfRevenue
1456895
us-gaap Cost Of Revenue
CostOfRevenue
248338
CY2017Q2 us-gaap Cost Of Services
CostOfServices
55660
CY2016Q2 us-gaap Cost Of Services
CostOfServices
66597
us-gaap Cost Of Services
CostOfServices
94480
us-gaap Cost Of Services
CostOfServices
122379
CY2017Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
417464
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
633062
CY2017Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8712
CY2016Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8712
us-gaap Depreciation
Depreciation
15513
us-gaap Depreciation
Depreciation
24577
CY2017Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
802500
CY2016Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
401250
CY2017Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
401250
CY2016Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
200625
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.57
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.53
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.53
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17289365
CY2017Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
CY2016Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-49468
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-49506
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-49506
CY2017Q2 us-gaap Gross Profit
GrossProfit
90920
CY2016Q2 us-gaap Gross Profit
GrossProfit
279324
us-gaap Gross Profit
GrossProfit
848321
us-gaap Gross Profit
GrossProfit
598068
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-133215
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-462136
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-715357
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1092661
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
86027
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-142234
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-215598
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-58359
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
101754
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
131394
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-24176
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-35098
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-16556
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4348
CY2017Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
166735
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
134132
CY2017Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8
CY2016Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
13
us-gaap Interest Paid
InterestPaid
us-gaap Interest Paid
InterestPaid
CY2017Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
341264
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
381762
CY2017Q2 us-gaap Inventory Net
InventoryNet
567182
CY2016Q4 us-gaap Inventory Net
InventoryNet
465428
CY2017Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
225918
CY2016Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
83666
CY2017Q2 us-gaap Liabilities
Liabilities
1974941
CY2016Q4 us-gaap Liabilities
Liabilities
1836477
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15387972
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-49493
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
1880257
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
1605352
us-gaap Operating Expenses
OperatingExpenses
3993851
us-gaap Operating Expenses
OperatingExpenses
3087278
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1789337
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1974941
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1836477
CY2017Q2 us-gaap License Costs
LicenseCosts
740301
CY2016Q2 us-gaap License Costs
LicenseCosts
69893
us-gaap License Costs
LicenseCosts
1362415
us-gaap License Costs
LicenseCosts
125959
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
919634
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-367095
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-140664
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-51783
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-851935
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1895535
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-1789329
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-1375489
us-gaap Net Income Loss
NetIncomeLoss
-3145516
us-gaap Net Income Loss
NetIncomeLoss
-2538703
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-2538703
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1989954
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1576114
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3546766
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2939953
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2939953
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-49461
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1326028
us-gaap Operating Income Loss
OperatingIncomeLoss
-3145530
us-gaap Operating Income Loss
OperatingIncomeLoss
-2489210
CY2017Q2 us-gaap Other Assets Current
OtherAssetsCurrent
29462
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
53638
CY2017Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
752820
CY2016Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
194888
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
1850568
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
340754
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
334476
CY2017Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
74420
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
80366
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
32619
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
140664
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
51783
CY2015Q4 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
180000
CY2017Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
200625
CY2016Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
200625
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
401250
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
401250
CY2016Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
401250
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
206677
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
203113
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Reclassification</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.2pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Reclassifications occurred to certain prior year amounts in order to conform to the current year classifications. The reclassifications have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on the reported net loss.</div></div></div></div></div></div>
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
153529
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
67814
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
500000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
449049
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
566448
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
942493
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1055849
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65946670
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-62801154
CY2017Q2 us-gaap Revenues
Revenues
886881
CY2016Q2 us-gaap Revenues
Revenues
415814
us-gaap Revenues
Revenues
2305216
us-gaap Revenues
Revenues
846406
CY2017Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
134061
CY2016Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
220926
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
454648
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
505652
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
15452888
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6359974
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5523072
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6228197
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1431208
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1038904
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3051358
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2031429
us-gaap Share Based Compensation
ShareBasedCompensation
564275
us-gaap Share Based Compensation
ShareBasedCompensation
184299
us-gaap Stock Issued1
StockIssued1
114585
us-gaap Stock Issued1
StockIssued1
CY2017Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
61667
CY2017Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
156584
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
13413031
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5516726
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5516726

Files In Submission

Name View Source Status
0001437749-17-014745-index-headers.html Edgar Link pending
0001437749-17-014745-index.html Edgar Link pending
0001437749-17-014745.txt Edgar Link pending
0001437749-17-014745-xbrl.zip Edgar Link pending
bkyi-20170630.xml Edgar Link completed
bkyi-20170630.xsd Edgar Link pending
bkyi-20170630_cal.xml Edgar Link unprocessable
bkyi-20170630_def.xml Edgar Link unprocessable
bkyi-20170630_lab.xml Edgar Link unprocessable
bkyi-20170630_pre.xml Edgar Link unprocessable
bkyi20170630_10q.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending